Last reviewed · How we verify
IN-C004
At a glance
| Generic name | IN-C004 |
|---|---|
| Sponsor | HK inno.N Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers (PHASE1)
- Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IN-C004 CI brief — competitive landscape report
- IN-C004 updates RSS · CI watch RSS
- HK inno.N Corporation portfolio CI